Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Asset Writedowns and Impairment (2012 - 2025)

Bio Key International recorded quarterly Asset Writedowns and Impairment of $15000.0 in Q1 2025, up 107.04% quarter-over-quarter from -$213005.0 in Q4 2024, and down 85.0% year-over-year from $100000.0 in Q1 2024.

Bio Key International's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $15000.0 for Q1 2025.

  • In Q1 2025, Asset Writedowns and Impairment fell 85.0% year-over-year to $15000.0; the TTM figure through Sep 2025 stood at -$198005.0 (down 118.22% YoY), while the FY2024 annual figure was -$213005.0, down 105.94% from the prior year.
  • Asset Writedowns and Impairment came in at $15000.0 for Q1 2025 at Bio Key International, up from -$213005.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.5 million in Q2 2023 to a low of -$213005.0 in Q4 2024.
  • A 3-year average of $484070.7 and a median of $100000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
  • Across the five-year window, Asset Writedowns and Impairment tumbled 119.6% in 2024 and sank 85.0% in 2025, its largest moves.
  • Bio Key International's Asset Writedowns and Impairment stood at $1.1 million in 2023, then sank by 119.6% to -$213005.0 in 2024, then jumped by 107.04% to $15000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $15000.0, -$213005.0, and -$100000.0 for Q1 2025, Q4 2024, and Q2 2024 respectively.

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 15,000.00
Mar 31, 2025 15,000.00
Dec 31, 2024 -213,005.00
Dec 31, 2024 -213,005.00
Jun 30, 2024 -100,000.00
Jun 30, 2024 -100,000.00
Mar 31, 2024 100,000.00
Mar 31, 2024 100,000.00
Dec 31, 2023 1.09 Mn
Dec 31, 2023 1.09 Mn
Sep 30, 2023 1.00 Mn
Sep 30, 2023 1.00 Mn
Jun 30, 2023 1.50 Mn
Jun 30, 2023 1.50 Mn
Mar 31, 2017 500,000.00
Mar 31, 2017 500,000.00
Dec 31, 2012 -270,000.00
Dec 31, 2012 -270,000.00
Sep 30, 2012 -300,000.00
Sep 30, 2012 -300,000.00